Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

Use the search and filter options below to find the resources you're looking for.

Related articles

Read our latest

2288 Resource s
2288 Resource s
    Date
    From
    To
  1. Shigella is the leading bacterial cause of childhood diarrhea, and infections can have long-term effects on growth and development. No licensed Shigella vaccines currently exist, but several promising candidates in development could become available in a few years. PATH conducted a series of studies to better understand the public health value of potential Shigella vaccines and help inform decisions by international agencies, funders, vaccine developers, and national policymakers. This included a multi-country feasibility and acceptability study with national stakeholders and healthcare providers in Burkina Faso, Ghana, Kenya, Nepal, and Vietnam to identify preferences and priorities for future Shigella vaccines. These briefs provide an overview of the results in each of the study countries.
    Published: November 2022
    Resource Page
    Part of a Series, Brief
  2. The Partnership for Vivax Elimination (PAVE) led by PATH and Medicines for Malaria Venture (MMV) brings together National Malaria Programs (NMPs), researchers, funders, and other organizations to support countries as they strive to achieve their elimination goals through:▪ Working with NMPs to identify optimal radical cure tools and strategies for their given contexts.▪ Generating and sharing high-quality evidence on Plasmodium vivax (P. vivax) case management to inform policy decisions and implementation by national governments▪ Advancing the development and availability of quality-assured medicines and diagnostics for P. vivax.
    Published: November 2022
    Resource Page
    Brief
  3. For over 30 years the PATH Diagnostics program has collaborated with partners across the full diagnostics ecosystem to develop and commercialize appropriate, affordable, quality-assured diagnostics that improve health outcomes of people and communities in low-resource settings.
    Published: November 2022
    Resource Page
    Fact Sheet
  4. PATH hosted the 2022 Vaccines Against Shigella and ETEC (VASE) Conference on November 29 to December 1, 2022, in Washington, DC. This international event shared cutting-edge research related to the development of vaccines against neglected diarrheal pathogens including Shigella, enterotoxigenic Escherichia coli (ETEC), Campylobacter, and non-typhoidal Salmonella. PATH received 139 abstracts for consideration in the scientific content of the meeting, and the final conference program featured 24 abstract-based oral presentations and 87 abstract-based poster presentations. This booklet provides the complete abstracts for all oral and poster presentations at VASE 2022.
    Published: November 2022
    Resource Page
    Report
  5. The Digital Health Ecosystem (DHE) project supports the sustainability and expansion of digital tools for health by helping local entrepreneurs more easily access financing, technical resources, and opportunities for scale. The DHE, in particular, will foster a global network of innovators building businesses on common open-source platforms, enabling them to focus on unmet needs while leveraging existing digital architectures and communities in countries. By doing so, innovators will face fewer barriers in scaling businesses that support health systems and expand country choice by offering local as well as global solutions.For more background information, please visit the article on this work.Call for Expressions of InterestIn July 2022, the Bayer-funded and PATH and Medic-led DHE released a Call for Expressions of Interest: Africa-based Digital Health Entrepreneurs to Expand Tools for Community Health. In support of this effort, Digital Square invited African businesses, organizations, and social entrepreneurs with software, content, and/or services to participate. The objective was to create a continent-wide list of qualifying respondents that could be available to donors, investors, and implementing partners worldwide.In their submissions, candidates had to demonstrate their ability to support the implementation of software tools and products. They also had to have an interest in engaging in the digital health space of a country, and a willingness to work with local governments and populations at scale, including populations that cannot directly purchase from vendors, but may be government beneficiaries. Finally, they had to be registered as a formal organization or business in the World Health Organization Africa Region, with sufficient accounting mechanisms to track revenue and expenditures.The EOI received a total of 175 submissions from 25 African countries. The six countries with the most submissions were Nigeria, Kenya, South Africa, Uganda, Tanzania, and Ethiopia.The submissions presented a wide array of offerings on topics such as telehealth, electronic medical records, supply chain systems, patient scheduling, and data use. More than half of the technologies have been on the market for 3 or more years. Of those, more than half have been available for 5 or more years, and a notable number have been available for at least 10 years, representing a healthy mix of market maturity.Evaluation of submissionsAll submissions were evaluated by a steering committee comprised of a diverse set of the foremost leaders and thinkers in digital health technology, including representatives from country governments, donor organizations, implementing organizations, technology vendors, and other groups.After completing the evaluations, the DHE team applied a scoring system with a 3-point scale based on the LESC’s evaluations. The DHE team then eliminated low scorers (1–1.5), included high scorers (2.5–3), and reevaluated mid-level scorers (1.6–2.4). The team also reevaluated any one organization where the two reviewers had more than a 0.5 differentiation in overall score. The LESC members then met with the DHE and Digital Square teams to discuss the outcomes and finalize the Africa-based Digital Health Entrepreneurs List, which consists of 112 of the 175 submissions received.The LESC evaluated submissions using formal, documented evaluation criteria available in Table 1 below.How to use this listThis list is intended to be a resource to help countries, donors, implementers, and the global digital health community identify possible local partners to leverage and adapt existing digital tools in response to improve health system challenges. It is intended to start conversations on potential partnerships with local, Africa-based entrepreneurs.Please note this list was curated in August 2022, and does NOT fully vet the technical quality or experience of the solutions and does not constitute an endorsement of the solutions listed.Users can download the list below. From there, users can filter their copy of the list by technological need, geographical need, or both.If you would like to provide feedback on the value of this list, please complete this form. We are also proactively following up with entrepreneurs on the list to assess what type of engagement resulted from this resource and how we can structure future public calls.
    Published: November 2022
    Resource Page
    Report